Colchicine was studied in a randomized controlled double-blind clinical trial in diabetic nephropathy where colchicine decreased neutrophil-related chronic inflammation; however, it did not lower creatinine, urinary albumin/creatinine ratio and did not prevent overt nephropathy either (137). This evidence concerns the gene ALB and diabetic kidney disease.